PREDICTORS OF SITE OF FRACTURE IN PATIENTS WITH HISTORY OF PARENTAL FRACTURE by Dey, Mrinalini & Bukhari, Marwan
Methods: All patients who were referred to the rheumatology
musculoskeletal ultrasound service were analysed within a three-
month time period in 2016 and 2017. 147 referrals were made within a
three-month time period from 3 June 2016 to 2 September 2016. 112
referrals were made between 7 April 2017 and 6 July 2017. Two
Consultant Rheumatologists carried out and reported the ultrasound
scans. Scans were carried out using a GE Logiq E machine. Synovitis
was defined as grey scale synovial hypertrophy or tenosynovitis, with
or without hyperaemia. Data was collected from both paper and
electronic patient records.
Results: The most frequent indication for scanning was screening for
synovitis which was the same as in 2016. There were 4.0% of patients
referred for US guided injections in 2017 compared to 2.1% in 2016.
The discharge rate for the rheumatology US service was 10.1% in
2017 compared to 5.0% in 2016. The non-attendance rate was 2.0%
in 2017 compared to 3.6% in 2016. 8.5% were anti-CCP positive in
2016 compared to 5.1% in 2017. 17.2% were rheumatoid factor
positive which is similar to 17.0% in 2016. 6.1% were dually sero-
positive in 2017 versus 6.4% in 2016. On reviewing the reports 96.0%
used the words synovial hypertrophy versus 91.5% in 2016, the
equivalent figures for erosions were 91.9% (82.3% in 2016) and 95.0%
for hyperaemia or power Doppler (91.5% in 2016). As a result of the
scan, a therapeutic intervention was made for 34.3% in 2017 versus
25.5% in 2016.
Conclusion: The patients had a similar serological profile in 2016 and
2017. The indications for scanning were consistent from year to year.
The quality of reports improved from 2016 to 2017. The introduction of
a new referral and booking system had a positive impact on discharge
and non-attendance rates respectively.
Disclosures: The authors have declared no conflicts of interest.
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NEW OUTPATIENT MANAGEMENT: EXPERIENCE FROM A
SINGLE CENTRE
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Background: The use of musculoskeletal ultrasound (MSKUS) in
rheumatology has rapidly evolved over the past decade, becoming a
valuable tool in the diagnosis and follow up of musculoskeletal
diseases. Increasingly more people are being referred for MSKUS in
rheumatology, and scans previously carried out by radiologists, are
now conducted by rheumatologists themselves. At Russells Hall
Hospital (RHH), two rheumatology consultants are trained in the use of
ultrasound imaging for rheumatological conditions. This study aims to
see how ultrasound is being used for new patients at RHH and assess
its impact.
Methods: This retrospective study looked into the rates and reasons
for MSKUS referrals of all new outpatients seen in the rheumatology
department of RHH in January 2017. The pre- and post- scan
diagnoses and the eventual outcomes were also recorded. We also
captured other related parameters including the waiting time and the
joints scanned. The data was collected from clinic letters and
ultrasound scan reports.
Results: Of the 142 new rheumatology outpatients reviewed in
January 2017, 17 (11.9%) were referred for MSKUS and 15 ultrasound
scan reports were available at the time this study was conducted.
Hands and wrists were the most frequently scanned joint areas (12/
15), while the rest involved peripheral joints of the feet. The most
common reason for new patient MSKUS referral was to investigate for
the presence of subclinical synovitis (12/15); 3/15 were to clarify a
differential diagnosis. The most common pre-scan diagnosis was non-
specific arthralgia or inflammatory arthritis (n¼ 6), followed by
osteoarthritis (n¼ 5). The most common post-scan diagnoses were
both normal (n¼6) and osteoarthritis (n¼ 6). Nine of the initial
impressions were altered post-scan with the use of MSKUS, five of
which were deemed normal. 7/15 patients were discharged either
immediately after the MSKUS or on their next clinic appointment. One
patient was diagnosed on the ultrasound as having rheumatoid arthritis
and was referred directly to the early rheumatoid arthritis clinic. The
median waiting time was 67 days (range 0-78 days). All the scans were
carried out in-house by the two rheumatology consultants with the
load equally distributed among them.
Conclusion: Ultrasound is a valuable tool for diagnosis of rheumatic
conditions. Identifying new onset inflammatory arthritis allows such
patients to be fast-tracked to an early arthritis service; conversely,
excluding inflammatory arthritis can allow some patients to be
discharged. Previously such patients may have been followed up for
months before being eventually discharged; MSKUS may reduce
these costs and inefficiencies. Defining our ultrasound referral rate is
helpful for future service planning and help in tackling the challenge of
reducing waiting times. Given that most scans were for small joints of
the hands and wrists, training rheumatologists to scan a limited range
of joints may meet demand and expedite training.
Disclosures: The authors have declared no conflicts of interest.
E17 PREDICTING PELVIC FRACTURES USING BONE
MINERAL DENSITY IN THE LUMBAR SPINE AND FEMORAL
NECK: A CASE-CONTROL STUDY
Kristen Davies1 and Marwan Bukhari2
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Background: Low bone mineral density (BMD) is classically asso-
ciated with an increased risk of fracture. We have previously
demonstrated that the femoral neck is a better predictor of fractures
than the lumbar spine. It is not known, however, whether BMD from
the lumbar spine or femoral neck is better at predicting fractures in the
pelvis.
Methods: Using a case-control study approach to investigate the
likelihood BMD in the lumbar spine, femoral neck and femur had on
predicting pelvic fractures in patients referred for BMD estimation
using dual X-ray absorptiometry (DEXA).
A cohort of patients attending for BMD estimation using DEXA in a
district general hospital between 2004 and 2011 were identified. The
patients who were referred with a pelvic fracture were identified.
Suitable controls matched for age, gender and body mass index were
selected from those patients who were referred without a fracture. The
risk factors assessed were femoral neck BMD, total femur BMD and
lumbar spine BMD (L1-L4). Comparisons between the fracture and
non-fracture group were identified using the student’s t-test. An
ordinal logistic regression model was used to determine the best
predictor of pelvic fracture.
Results: 316 patients were referred with a pelvic fracture in the study
period. Mean age was 67.2 years (SD 12.3). 280 patients (89%) were
female. In the pelvic fracture cohort, males were found to have a
significantly higher BMD in the right femoral neck (mean difference
0.09g/cm2, p value 0.005), left and right femurs (mean difference left
0.06g/cm2 p value 0.049, right mean difference 0.10g/cm2, p value
0.0072) and in the lumbar spine (mean difference 0.07g/cm2, p value
0.0374). BMD was significantly lower in the pelvic fracture cohort in the
femoral neck (mean difference left and right 0.09g/cm2), left and right
femurs (mean difference left 0.08g/cm2, right 0.1g/cm2) and the
lumbar spine (mean difference 0.1g/cm2), all with a p value
of<0.0001. Our Ordinal logistic regression model demonstrated that
the BMD of left and right femoral necks are the strongest predictors of
pelvic fracture (both p value <0.0000), followed by the BMD of left and
right femurs (p value <0.00029 and <0.00004, respectively). The
lumbar spine was deemed a non-significant predictor (p value 0.175).
Conclusion: In this cohort of patients, we have demonstrated that the
BMD of the left and right femoral necks are the strongest predictors of
pelvic fracture. The BMD of left and right femurs are also statistically
significant predictors of pelvic fracture. The lumbar spine was found
not to be relevant. These results support our previous findings that the
femoral neck is a better predictor of fractures than the lumbar spine.
Validation for other fractures is required.
Disclosures: The authors have declared no conflicts of interest.
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Background: Parental history of fragility fracture (FF) confers an
increased risk of further FF in all sites, independent of bone mineral
density (BMD). Factors affecting site of FF in these patients are
unknown. These were analysed in patients attending for BMD
estimation.
Methods: Patients attending for dual energy X-ray absorptiometry
scanning, between 2004 and 2016, with a history of parental FF, were
included. Parameters recorded: femoral and vertebral BMD, height,
weight, fat mass, age, smoking, alcohol, corticosteroid therapy,
aromatase inhibitor therapy, Depo-Provera use, hormone replacement
therapy, rheumatoid arthritis, polymyalgia rheumatica, breast or
prostate cancer, coeliac disease, and site of fracture. Only patients
with a single fracture were included. Logistic models were fitted to
model site of FF, compared to all other FF in the cohort using the risk
factors above.
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Results: 6053 patients (91% female) were included. 2094 patients
(34.6%) had sustained a discreet FF. Table 1 shows factors affecting
fracture risk at various sites. In general, smoking, alcohol, aromatase
inhibitors, increasing age, height, and weight increased fracture risk in
all long bones. HRT increased fracture risk in the arm and spine;
female gender increased the risk in the leg and ribs. Corticosteroids
increased the risk in the forearm and ribs. Rheumatoid arthritis
increased fracture risk in the femur. Vertebral fracture risk was
increased with all the above factors, and coeliac disease. Decreased
right femoral BMD and vertebral BMD were associated with increased
risk of fracture at all sites.
Conclusion: Different sites of fracture appear to be associated with
different risk factors. The most common sites of fracture in our cohort
were the peripheral long bones and vertebrae, with femur being the
least common. As in the general population, corticosteroids, smoking,
alcohol and aromatase inhibitors increase fracture risk in the long
bones and vertebrae. Rheumatoid arthritis significantly increases
fracture risk in the femur and spine suggesting a novel mechanism
by which this occurs. Limitations of this study include lack of
information on multiple fractures in one individual, and lack of dose
and duration of medications.
Disclosures: The authors have declared no conflicts of interest.
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Simon Beardmore4 and Manoj Samaranayake5
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Background: One in five men over the age of 50 will experience an
osteoporosis-related fracture. The reference ranges used to diagnose
osteoporosis in men are currently based on the mean BMD for young
healthy women; however, the WHO has suggested that there should
be separate criteria for men. Despite a growing body of evidence,
osteoporosis in men remains an under-researched topic. In this study,
we aim to ascertain if and how FRAX risk factors relate to previous
fragility fractures in men, and how this varies across age groups.
Methods: Data relating to all the components of FRAX was collected
retrospectively for 257 patients who had received DEXA scans at
Royal Preston Hospital. This was analysed using logistic regression
with previous fracture as the outcome variable. It was also split into
three age groups with rates of osteopenia, osteoporosis and the FRAX
risk factors identified for each group.
Results: BMD measurement at the hip identified more cases of
osteoporosis than at the spine in the over 75 age group. This is likely
due to degenerative changes at the spine artificially increasing the
BMD. Conversely, BMD measurement at the spine was found to be a
statistically significant risk factor for fragility fracture (OR¼0.05,
P¼0.001). Findings for BMD at the hip were not statistically
significant. Glucocorticoid use and secondary osteoporosis were
inversely correlated with fragility fracture. This is likely due to the
fact that they had been referred for DEXA scanning as a preventative
measure and started on prophylactic treatment for osteoporosis.
Alcohol and smoking were associated with an increased risk of fragility
fracture; however, this was not statistically significant.
Conclusion: Our findings show that BMDmeasurement at the spine is
associated with fracture risk in men. However, currently only BMD at
the hip is used in the FRAX tool. Therefore we suggest that BMD
measurement at the spine could be considered as an addition to the
FRAX tool, especially in men. Our literature search showed that lateral
DEXA measurements at the lumbar spine may be useful in older men
where degenerative changes affect measurements at the spine. Our
findings do not contradict the use of alcohol and smoking in the FRAX
tool.
Disclosures: The authors have declared no conflicts of interest.
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